- 1(current)
Q. No.Match the following columns and select the correct option.
| Column-I | Column-II | ||
| a. | Bt cotton | (i) | Gene therapy |
| b. | Adenosine deaminase deficiency | (ii) | Cellular defense |
| c. | RNAi | (iii) | Detection of HIV infection |
| d. | PCR | (iv) | Bacillus thuringiensis |
| a | b | c | d | |
| 1. | (iii) | (ii) | (i) | (iv) |
| 2. | (ii) | (iii) | (iv) | (i) |
| 3. | (i) | (ii) | (iii) | (iv) |
| 4. | (iv) | (i) | (ii) | (iii) |
Subtopic: Â Bt Crops |Â Interference RNA Tech |Â Gene Therapy |Â Molecular Diagnosis |
 93%
From NCERT
NEET - 2020
To view explanation, please take trial in the course.
NEET 2026 - Target Batch - Vital
Hints
To view explanation, please take trial in the course.
NEET 2026 - Target Batch - Vital
| Assertion(A): | Functional ADA cDNA genes must be inserted in the lymphocytes at the early embryonic stage to treat SCID. |
| Reason(R): | Cells in the embryonic stage are mortal, differentiated and easy to manipulate. |
| 1. | Both (A) and (R) are true and (R) is the correct explanation of (A). |
| 2. | Both (A) and (R) are true and (R) is not the correct explanation of (A). |
| 3. | (A) is true but (R) is false. |
| 4. | (A) is False but (R) is true. |
Subtopic: Â Gene Therapy |
To view explanation, please take trial in the course.
NEET 2026 - Target Batch - Vital
Hints
Read the following statements:
How many of the above statements are correct?
1. Three
2. Four
3. Two
4. One
| (i) | Hybridoma is a cell produced by the fusion of two cells of different origin |
| (ii) | ADA deficiency can be cured by bone marrow transplantation which is a permanent cure |
| (iii) | All genetically modified organisms (GMO) are transgenic organisms |
| (iv) | IFN belong to a group of glycoprotein called cytokines |
| (v) | Pseudomonas putida can degrade toluene, camphor, octance and xylene |
How many of the above statements are correct?
1. Three
2. Four
3. Two
4. One
Subtopic: Â Gene Therapy |
Sorry!! currently, the explanation for the question is not provided. If you need further help, please email at support@neetprep.com with subject: Explanation Missing for Question Id: 362358
Hints
Sorry!! currently, the explanation for the question is not provided. If you need further help, please email at support@neetprep.com with subject: Explanation Missing for Question Id: 362358
Find the true (T)/false (F) statements and choose the correct option.
I. GMO may lead to health risk in humans
II. Interferons were discovered by Issacs and Lindenmann
III. Interferons can cure AIDS
IV. Antibodies derived from a single clone of cells which recognize only one kind of antigen, are called monoclonal antiobodies
I. GMO may lead to health risk in humans
II. Interferons were discovered by Issacs and Lindenmann
III. Interferons can cure AIDS
IV. Antibodies derived from a single clone of cells which recognize only one kind of antigen, are called monoclonal antiobodies
| I | II | III | IV | |
| 1. | T | T | F | T |
| 2. | T | T | T | T |
| 3. | F | T | T | T |
| 4. | T | F | F | T |
Subtopic: Â Gene Therapy |Â Transgenic Microbes & Animals |
To view explanation, please take trial in the course.
NEET 2026 - Target Batch - Vital
Hints
Match List - I with List - II
Choose the correct answer from the options given below:
| List-I | List-II | ||
| (A) | Gene therapy | (I) | Separation of DNA fragments |
| (B) | RNA interference | (II) | Diagnostic test for AIDS |
| (C) | ELISA | (III) | Cellular defense |
| (D) | Gel Electrophoresis | (IV) | Allows correction of a gene defect |
Choose the correct answer from the options given below:
| Options: | (A) | (B) | (C) | (D) |
| 1. | IV | I | II | III |
| 2. | IV | II | III | I |
| 3. | IV | III | II | I |
| 4. | IV | III | I | II |
Subtopic: Â Interference RNA Tech |Â Med Applications & Humulin |Â Gene Therapy |Â Molecular Diagnosis |
 91%
From NCERT
NEET - 2023
To view explanation, please take trial in the course.
NEET 2026 - Target Batch - Vital
Hints
To view explanation, please take trial in the course.
NEET 2026 - Target Batch - Vital
- 1(current)
Q. No.
© 2025 GoodEd Technologies Pvt. Ltd.